This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
S&P 500's Second-Best Week in 2022: Best Leveraged ETFs
by Sanghamitra Saha
U.S. stocks saw a massive jump on the final trading session of last week, making the week successful one.
5 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
The S&P 500 hit to record close last week, as investors gained optimism from some of President Joe Biden's encouraging announcements regarding booster shots and testing kits.
5 Best Inverse/Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week with all notable U.S. indexes being in the red. Rising inflation, hawkish Fed and fast-spreading Omicron variant of COVID-19 led to this bloodbath.
Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
5 Best-Performing Leveraged ETFs of August
by Sweta Killa
The MSCI's broadest index of world stocks on its best run of monthly gains since 2017-2018.
7 Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week. News of zero new cases in China, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine and no new flare-up in taper talks led to the gains.
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
by Sweta Killa
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
5 Best Inverse/Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Last week was upbeat for Wall Street. Stocks basically ignored myriad of concerns including inflationary pressures and rising Delta variant of COVID-19 cases.
5 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
We highlight a few leveraged ETF areas that won last week.
Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike.